Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease. - Test2 - elhamkhani - TriplyDB

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

http://www.wikidata.org/entity/Q39392775

about

Bioactivity of Olive Oil Phenols in Neuroprotection.Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease.Autophagy in inflammation: the p38α MAPK-ULK1 axis.17β-Estradiol Regulates Microglia Activation and Polarization in the Hippocampus Following Global Cerebral Ischemia.Microglial Lectins in Health and Neurological Diseases.Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease Importance of GPCR-Mediated Microglial Activation in Alzheimer's Disease Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an MPTP Model of Parkinson's Disease

P2860

Q47099956-E273BEBF-9FF5-46E4-8A6C-D6AA1138E6A1 Q47108252-FE507179-B7CA-43B3-9E37-43FF5FBE5B67 Q47868304-C21CAB20-B1F2-4399-9742-0343F70AC69C Q52640400-01AA47FF-E37F-47D9-ABA6-43B4D8601C72 Q54111953-AF19317C-2531-4999-BB8F-BF1836247240 Q54967605-477C5E3F-8BA5-497E-B079-9A59BB315307 Q54988763-49E228B8-14C1-41F9-9994-6B3ADCFD5BB1 Q57817388-C66E40D9-4DBE-4162-9A11-EF1AFEC1BC49 Q58729326-6B5267F9-F63A-420B-BB01-3901F2C5B32D Q58799111-F2F23EEB-A02F-4E26-AF13-352CE2258470 Q59136331-3F78BC39-7B27-4BDF-8E21-9F5D1776BEB1 Q59136411-0C130325-72F9-42FE-B20C-B1C3811766F2

P2860

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

http://www.wikidata.org/entity/Q39392775

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

@en

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

@nl

type

label

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

@en

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

@nl

prefLabel

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

@en

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

@nl

P1433

Q39392775-719230E7-1ADD-4A81-8E02-6F2ABBC1A1E7

P1476

Q39392775-DF9D6C6D-BAF7-4F18-BF1C-70E889F04540

P2093

Q39392775-78002306-06AC-4388-8171-EA533D099DC0

Q39392775-FDE4CE3A-8617-4245-A450-7AF9C5FF4251

P2860

Q39392775-00A71430-D3D8-4D8A-BDA1-E0A13CF0DE09

Q39392775-0134F78B-6EEE-42EF-8DA9-BA3712AB26B6

Q39392775-02DEE6A0-803B-4DAC-BDA5-D7454B84486A

Q39392775-03C107ED-F44B-43F8-ABD6-8B5AB23A5A4F

Q39392775-03CA55AA-7E43-444F-8C10-E2B914FF9E99

Q39392775-04BDF82D-3737-4820-AD33-30C3C3017794

Q39392775-0718EFEA-EAB1-4F20-9644-F98640AFCA60

Q39392775-07A530D3-5395-4561-A27D-7A2193F1411F

Q39392775-0A90FAF5-75E7-46A7-AC6E-553A9B86D116

Q39392775-0CC30BD1-0A36-4D8F-B717-B610A709F9E9

P304

Q39392775-9E6AEFA4-D7EF-47FC-8901-0C830383645A

P31

Q39392775-000EB692-3DAC-4207-8253-38EC1B22A11D

P356

Q39392775-0DE0A508-A3F4-460B-8213-969322F602DD

P478

Q39392775-92CAB46D-22EA-4DDE-A9B4-7489D5E1C72B

P577

Q39392775-6A282DCD-F26E-497B-BFA8-2B266FA59EFD

P698

Q39392775-6D9316E6-03BC-4A65-94CF-0DA6BE36C45F

P921

Q39392775-6F3A90BB-712B-4681-B246-4F34F40FA60A

Q39392775-B6691F37-9210-4214-8F12-BAFB7C6650E8

P932

Q39392775-28AA819E-C20C-421A-ADB7-ECD715FCE18B

P356

FNAGI.2017.00176

P1433

Frontiers in Aging Neuroscience

P1476

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.

@en

P2093

Howard J Federoff

http://www.w3.org/2001/XMLSchema#string

Sudhakar R Subramaniam

http://www.w3.org/2001/XMLSchema#string

P2860

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice

Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies

TLR signaling pathways

Use of ibuprofen and risk of Parkinson disease

Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials

Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1

P304

176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2017.00176

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28642697

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5463358

http://www.w3.org/2001/XMLSchema#string